Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates

被引:38
作者
Bonfiglio, G
Cascone, C
Azzarelli, C
Cafiso, V
Marchetti, F
Stefani, S
机构
[1] Univ Catania, Dipartimento Sci Microbiol, I-95124 Catania, Italy
[2] GlaxoWellcome SPA, Direz Med, Verona, Italy
关键词
D O I
10.1093/jac/45.1.115
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 10(4) and 10(6) cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but only 58.3% were susceptible to ofloxacin; at the higher inoculum, 78.3% were susceptible to levofloxacin and 36.7% to ofloxacin. In time-kill studies, levofloxacin exerted bactericidal activity within 4 h. With ofloxacin and ciprofloxacin bacterial regrowth was observed after 8 h. Levofloxacin may represent an alternative drug in the treatment of infections caused by S. maltophilia.
引用
收藏
页码:115 / 117
页数:3
相关论文
共 10 条
[1]   SUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS OF MUTANT STRAINS OF XANTHOMONAS-MALTOPHILIA WITH HIGH-LEVEL AND LOW-LEVEL CONSTITUTIVE EXPRESSION OF L1 AND L2 BETA-LACTAMASES [J].
AKOVA, M ;
BONFIGLIO, G ;
LIVERMORE, DM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1991, 35 (04) :208-213
[2]   EFFECT OF MEDIA COMPOSITION ON THE SUSCEPTIBILITY OF XANTHOMONAS-MALTOPHILIA TO BETA-LACTAM ANTIBIOTICS [J].
BONFIGLIO, G ;
LIVERMORE, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (06) :837-842
[3]   LEVOFLOXACIN A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETICS AND THERAPEUTIC EFFICACY [J].
DAVIS, R ;
BRYSON, HM .
DRUGS, 1994, 47 (04) :677-700
[4]   Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia [J].
Denton, M ;
Kerr, KG .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) :57-+
[5]   TRANSFERABLE AMIKACIN RESISTANCE IN PSEUDOMONAS MALTOPHILIA AND ACINETOBACTER CALCOACETICUS [J].
KRCMERY, V ;
ANTAL, M ;
LANGSADL, L ;
KNOTHE, H .
INFECTION, 1985, 13 (02) :89-90
[6]   SUSCEPTIBILITY OF XANTHOMONAS-MALTOPHILIA TO 6 QUINOLONES AND STUDY OF OUTER-MEMBRANE PROTEINS IN RESISTANT MUTANTS SELECTED INVITRO [J].
LECSOBORNET, M ;
PIERRE, J ;
SARKISKARAM, D ;
LUBERA, S ;
BERGOGNEBEREZIN, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :669-671
[7]   XANTHOMONAS-MALTOPHILIA - AN EMERGING NOSOCOMIAL PATHOGEN [J].
MARSHALL, WF ;
KEATING, MR ;
ANHALT, JP ;
STECKELBERG, JM .
MAYO CLINIC PROCEEDINGS, 1989, 64 (09) :1097-1104
[8]  
METT H, 1988, REV INFECT DIS, V10, P765
[9]  
Stefani S, 1998, DRUG EXP CLIN RES, V24, P105
[10]   A CHANGING PATTERN OF SUSCEPTIBILITY OF XANTHOMONAS-MALTOPHILIA TO ANTIMICROBIAL AGENTS - IMPLICATIONS FOR THERAPY [J].
VARTIVARIAN, S ;
ANAISSIE, E ;
BODEY, G ;
SPRIGG, H ;
ROLSTON, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :624-627